Prevalence of Hepatitis B and Hepatitis C Infections among Multi-transfused Thalassaemic Patients

  title={Prevalence of Hepatitis B and Hepatitis C Infections among Multi-transfused Thalassaemic Patients},
  author={Atm Emdadul Haque and Husni Zaim bin Ab Latiff},
Objective: Therefore this study was aimed to determine the prevalence of Hepatitis B and C infections among the multi-transfused Thalassaemic patients. Methodology: The medical records of total 100 patients with thalassaemia attending the Day Care Ambulatory Unit for blood transfusion in Raja Permaisuri Bainun Hospital was collected in order to extract relevant information pertaining to the study. Results: Among the 100 multi-transfused thalassaemic patients, 48% were females and 52% were males… 
2 Citations

Figures and Tables from this paper

Prevalence of transfusion-transmitted infections in multiple blood transfusion-dependent thalassemic patients in Asia: A systemic review
This systemic review aims to assess the prevalence of TTIs in transfusion-dependent β-thalassemia patients in Asia and concludes that robust national policies and hemovigilance are required to detect and mitigate the infection risk.
Surface Antigen (HBsAg) Negative Hepatitis B virus in Bangladesh: Warrants the Screening for Blood Donors
It is proved that blood donor screening methods & tests are not adequate & appropriate according to WHO according to World Health Organization.


Prevalence of Hepatitis C among Multi-transfused Thalassaemic Patients in Oman: Single centre experience.
It is likely that the high prevalence ofHCV among multi-transfused thalassaemic patients in Oman is due to blood transfusions dating from before the implementation of HCV screening in 1991 as the risk of HCv-associated transfusions has significantly reduced since then.
Prevalence of Anti HCV Infection in Patients with Beta-Thalassemia in Isfahan-Iran
It was revealed that blood transfusion was the main risk factors for HCV infection among beta-thalassemic patients, and more blood donor screening programs and effective screening techniques are needed to prevent transmission of HCV infected patients.
Transfusion Transmitted Hepatitis: Where Do We Stand Now? A One Center Study in Upper Egypt
Transfusion-transmitted hepatitis is still a major problem for multitransfused children in Egypt and more effort is required to reduce the infection rate through proper screening of blood and blood products, strict emphasis on receiving the vaccine, regular follow-up for those children with a hepatitis B antibody titer, and providing booster doses for those in need.
A study of hepatitis B and C prevalence and liver function in multiply transfused thalassemic and their parents.
It is argued that HCV constitutes a greater long term threat than HBV in these patients due to the higher incidence of chronic liver disease and the introduction of HCV screening of donated blood as well as reinforcing the importance of HBV screening and immunization.
Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study.
The prevalence of HCV infection is much higher among Iranian beta-thalassemic patients as compared with HBV and HIV infections, and routine screening of donated blood for HCV is highly recommended.
Common transfusion-transmitted infectious agents among thalassaemic children in Bangladesh.
It is recommended that the safe blood-transfusion programme be strengthened and mass vaccination against HBV (even who suffer from HCV) in Bangladesh be undertaken.
Clinical outcomes after transfusion-associated hepatitis C.
In a group of patients seen at a referral center, chronic post-transfusion hepatitis C was a progressive disease and, in some patients, led to death from either liver failure or hepatocellular carcinoma.
Study on effectiveness of transfusion program in thalassemia major patients receiving multiple blood transfusions at a transfusion centre in Western India
The study suggests the need to step up the transfusions to achieve hemoglobin goal of 10 gm% (as per the moderate transfusion regimen) and also to institute urgent and effective chelation measures with the aim of keeping serum ferritin levels below 1000 ng/ml to avoid the systemic effects of iron overload.
Hepatitis C Virus in Arab World: A State of Concern
Strategic strategies and clear policy of intervention are urgently needed to combat the consequences of HCV both regionally and at state level of each country.
Antibodies to hepatitis C virus in thalassemia.
The presence of anti-HCV antibodies has been examined in a group of 256 consecutive thalassemic patients who received blood transfusions in several countries around the world, and the anti-seropositivity correlated highly with serum transaminase elevation and with histological diagnoses of chronic active hepatitis.